DEEPAK NANDA focuses on transactional and securities matters, including cross-border mergers and acquisitions, dispositions, privatization transactions, leveraged recapitalizations and buyouts; venture capital and private equity fund formation and portfolio company investment; public and private offerings of equity and debt securities; public corporation securities laws and reporting compliance; and structured finance transactions.
Deepak has significant experience in the medical device, financial services, pharmaceutical, information technology, and media and entertainment sectors. His clients have included medical device companies, financial institutions, multinational manufacturing and technology companies, and pharmaceutical companies in the United States, Europe, and Asia. Deepak’s practice has included representing clients with projects in the United States, Europe, the Middle-East, India, Singapore, China, South Korea, Canada, Latin America, and Australia.
Deepak was recognized as a leading practitioner in Legal 500 (2010–2011) and was previously selected for inclusion in the 2007 Southern California Super Lawyers “Rising Stars” list. In June 2010, Diversity MBA Magazine named Deepak to its list of “Top 100 under 50 Diverse Executive & Emerging Leaders.”